ABSTRACT
Activation of T lymphocytes is thought to require at least two signals, one delivered by the T-cell receptor complex after antigen recognition, and one provided on engagement of co-stimulatory receptors, such as CD28. Recent studies are providing clues as to the specific signalling roles of co-stimulatory receptors. Furthermore, superimposition of inhibitory signals, such as those delivered by cytotoxic T-lymphocyte antigen 4 (CTLA-4), leads to a complex network of positive and negative co-stimulatory signals, the integration of which modulates immune responses.
Subject(s)
Antigens, Differentiation/metabolism , CD28 Antigens/metabolism , Immunoconjugates , T-Lymphocytes/immunology , Abatacept , Animals , Antigens, CD/metabolism , B7-1 Antigen/metabolism , B7-2 Antigen , CTLA-4 Antigen , Humans , Immune Tolerance , Lymphocyte Activation , Membrane Glycoproteins/metabolism , Mice , Models, Immunological , Receptors, Antigen, T-Cell/metabolism , Signal TransductionABSTRACT
Recent studies of T cell anergy induction have produced conflicting conclusions as to the role of the negative regulatory receptor, CTLA-4. Several in vivo models of tolerance have implicated the interaction of CTLA-4 and its ligands, B7.1 and B7.2, as an essential step in induction of anergy, while results from a number of other systems have indicated that signals from the TCR/CD3 complex alone are sufficient to induce T cell unresponsiveness. One explanation for this disparity is that the requirements for anergy induction depend closely on the details of the system: in vivo vs in vitro, route of stimulus administration, naive vs memory cells, CD4(+) vs CD8(+) cells, etc. To test this possibility, we established an in vivo anergy model using mice transgenic for the 2C TCR on a recombination-activating gene-2-deficient background, that either express or lack the CTLA-4 molecule. This system provides us with a very homogeneous pool of naive Ag-specific CD8(+) T cells, allowing us to control some of the conditions mentioned above. We found that T cells from CTLA-4-deficient mice were anergized by injections of soluble antigenic peptide as efficiently as were CTLA-4-expressing cells. These results indicate that CTLA-4 is not universally required for in vivo T cell anergy induction and may point to distinctions between regulation of peripheral tolerance in CD4(+) and CD8(+) T cells.
Subject(s)
Antigens, Differentiation/physiology , CD8-Positive T-Lymphocytes/immunology , Clonal Anergy , Immunoconjugates , Abatacept , Animals , Antigens, CD , CTLA-4 Antigen , Mice , Mice, Inbred C57BL , Mice, Transgenic , Receptors, Antigen, T-Cell/physiologyABSTRACT
Immunologic tolerance in T lymphocytes is maintained through both thymic and peripheral contributions. One peripheral tolerance mechanism is the induction of T cell anergy, a form of nonresponsiveness resulting from incomplete T cell activation, such as stimulation through the TCR in the absence of costimulation. Recent reports have suggested that engagement of the inhibitory receptor CTLA-4 by its B7 ligand is critical for the initiation of anergy. We tested the importance of CTLA-4 in anergy induction in primary T cells with an in vitro anergy system. Using both CTLA-4/B7-blocking agents and CTLA-4-deficient T cells, we found that T cell anergy can be established in the absence of CTLA-4 expression and/or function. Even in the absence of CTLA-4 signal transduction, T cells activated solely through TCR ligation lose the ability to proliferate as a result of autocrine IL-2 production upon subsequent receptor engagement. Thus, CTLA-4 signaling is not required for the development of T cell anergy.
Subject(s)
Antigens, CD/metabolism , Antigens, Differentiation/metabolism , B7-1 Antigen/metabolism , Clonal Anergy , Immunoconjugates , Membrane Glycoproteins/metabolism , T-Lymphocytes/immunology , T-Lymphocytes/metabolism , Abatacept , Amino Acid Sequence , Animals , Antibodies, Blocking/pharmacology , Antibodies, Monoclonal/pharmacology , Antigens, CD/genetics , Antigens, Differentiation/genetics , Antigens, Differentiation/immunology , Antigens, Differentiation/pharmacology , B7-1 Antigen/genetics , B7-1 Antigen/immunology , B7-2 Antigen , CTLA-4 Antigen , Cell Line , Clonal Anergy/genetics , Clone Cells , Female , Membrane Glycoproteins/antagonists & inhibitors , Membrane Glycoproteins/deficiency , Membrane Glycoproteins/genetics , Mice , Mice, Inbred C57BL , Mice, Transgenic , Molecular Sequence DataABSTRACT
Without receptor stimulation, cells from multicellular organisms die by apoptosis. Here we show that lymphocytes deprived of receptor stimulation undergo progressive atrophy before commitment to apoptosis. Following loss of receptor engagement, lymphocytes rapidly downregulated the glucose transporter, glut1. This was accompanied by reduction in mitochondrial potential and cellular ATP, suggesting that atrophy resulted from depletion of glucose-derived metabolic substrates. Expression of the antiapoptotic protein, Bcl-X(L), prevented death but not atrophy following either growth factor or glucose withdrawal. In Bcl-X(L) transgenic animals, size and metabolic activity of naive T cells were regulated through the TCR and correlated with TCR-dependent glut1 expression. These data suggest that ligands for cell-specific receptors promote cell survival by regulating nutrient uptake and utilization.